# An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

> **NCT05559177** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shanghai Pudong Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Recurrent or Metastatic Bladder Cancer

## Interventions

- **BIOLOGICAL:** Chimeric exosomal tumor vaccines

## Key facts

- **NCT ID:** NCT05559177
- **Lead sponsor:** Shanghai Pudong Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05559177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05559177, "An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05559177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*